Date: April 15th, 2026
Time: 10am-4pm
Location: Indianapolis, IN
Tufts Center for the Study of Drug Development (CSDD) is convening a closed-door senior executive session to explore innovative new approaches for pharmaceutical companies to collectively address one of the most persistent challenges in oncology development: enrolling U.S.-based participants into cancer clinical trials.
Despite significant investments in new recruitment strategies and operational tactics, the industry has seen limited sustainable improvement in patient enrollment. This exclusive, pre-competitive meeting will bring together senior leaders in clinical operations and medical affairs from sponsor organizations with deep oncology development portfolios to explore bold, collaborative solutions.
Hosted at Lilly Corporate Center in Indianapolis, this roundtable will focus on identifying new opportunities to rethink how cancer clinical trials are designed, communicated, and executed. Participants will engage in candid discussions on how the industry can work together to increase public and patient awareness, develop new engagement strategies, and uniquely position cancer clinical trials to improve participation in the United States.
This executive session is designed to foster open dialogue among industry leaders and generate actionable ideas that can help move the field forward.
Register Now
View the agenda and register to participate. If you are unable to attend, please submit a colleague from your organization who may be able to attend.
Agenda
Approximate Time | Focus |
10 – 10:30am | Welcome and Introductions |
10:30 – 11:00 | Setting the Stage: Context and Current Realities |
11:00- 12:00 | Exploring Solutions- Panels and Presentations |
12:00-12:30 | Lunch |
12:30- 1:30 | Examining Solutions - Panels and Presentations (continued) |
1:30 – 3:30pm | Facilitated Discussion on Collective Innovative Solutions |
3:30 – 4:00pm | Next Steps |